A randomized trial of candidate inactivated quadrivalent influenza vaccine versus trivalent influenza vaccines in children aged 3-17 years.
about
The 2009 H1N1 Pandemic Influenza in KoreaProtection of young children from influenza through universal vaccination.Immunogenicity and Safety of an Inactivated Quadrivalent Influenza Vaccine in US Children 6-35 Months of Age During 2013-2014: Results From A Phase II Randomized Trial.Advances in pediatric pharmacology, therapeutics, and toxicology.Quadrivalent influenza vaccine in the United States.Cost-effectiveness evaluation of quadrivalent influenza vaccines for seasonal influenza prevention: a dynamic modeling study of Canada and the United Kingdom.Immunogenicity and Reactogenicity of an Inactivated Quadrivalent Influenza Vaccine Administered Intramuscularly to Children 6 to 35 Months of Age in 2012-2013: A Randomized, Double-Blind, Controlled, Multicenter, Multicountry, Clinical TrialDetection of influenza B lineages from 2001 to 2013 in a tertiary hospital in the city of São Paulo, Brazil.Influenza B virus-specific CD8+ T-lymphocytes strongly cross-react with viruses of the opposing influenza B lineageComparative Epidemiology of Influenza B Yamagata- and Victoria-Lineage Viruses in Households.Quadrivalent influenza vaccine: a new opportunity to reduce the influenza burden.Evaluating the case for trivalent or quadrivalent influenza vaccines.A randomized controlled study to evaluate the immunogenicity of a trivalent inactivated seasonal influenza vaccine at two dosages in children 6 to 35 months of ageEpidemiology of influenza B in Australia: 2001-2014 influenza seasons.Inactivated quadrivalent split-virus seasonal influenza vaccine (Fluarix® quadrivalent): a review of its use in the prevention of disease caused by influenza A and B.Influenza vaccines: from whole virus preparations to recombinant protein technology.Key issues and challenges in estimating the impact and cost-effectiveness of quadrivalent influenza vaccination.Fluarix quadrivalent vaccine for influenza.Evidence update: GlaxoSmithKline's inactivated quadrivalent influenza vaccines.A review of the value of quadrivalent influenza vaccines and their potential contribution to influenza control.Assessing Fever Frequency After Pediatric Live Attenuated Versus Inactivated Influenza Vaccination.Cost-effectiveness analysis of quadrivalent seasonal influenza vaccines in England.Immunogenicity and safety of an inactivated quadrivalent influenza vaccine candidate versus inactivated trivalent influenza vaccines in participants >/=3 years of age: A double-blind, randomized, parallel-controlled phase III clinical trial in ChinaTime to Change Dosing of Inactivated Quadrivalent Influenza Vaccine in Young Children: Evidence From a Phase III, Randomized, Controlled Trial.Advances in Vaccines to Prevent Viral Respiratory Illnesses in Children.[Vaccinations from the pulmonologist's point of view].[Quadrivalent influenza vaccines].Immunogenicity and Safety of the New Inactivated Quadrivalent Influenza Vaccine Vaxigrip Tetra: Preliminary Results in Children ≥6 Months and Older Adults.Assessment of an optimized manufacturing process for inactivated quadrivalent influenza vaccine: a phase III, randomized, double-blind, safety and immunogenicity study in children and adults.Safety and Immunogenicity of an Egg-Cultivated Quadrivalent Inactivated Split-virion Influenza Vaccine (GC3110A) in Healthy Korean Children: a Randomized, Double-blinded, Active-controlled Phase III Study.Will a Quadrivalent Vaccine Solve the Problem of Influenza B Mismatches?
P2860
Q26749483-7C0B782E-D303-4DEE-A274-9D62AC119730Q27693242-3FF8C621-CB6B-4B15-9A0E-D04757184546Q33609256-D50A79A6-390A-421E-A13B-6C334E71B495Q33998667-B870C6B2-06AA-478F-A9E3-FD5FE841767DQ34033810-5C85BA13-E866-457A-9504-C3DE91BCE5E2Q35821862-93A875E4-97DB-4903-9A4C-3AB81E54C179Q36009631-05098F64-7634-431A-A0AF-E29C009BEA28Q36059666-C41346B2-B91B-42BA-99A6-5D54CF6A823AQ36376605-B4E185B1-C5EC-4C1E-8D12-7CA298830039Q36468830-5EA3D9D2-3B15-4759-9C58-7CF41B772B8BQ37011571-1C58AB7D-5FF1-4FDE-A3C3-A4988F00525EQ37375959-BB79C6AC-3A21-451A-8D60-10699ECF83FDQ37530395-2A23BD9C-C392-42AA-8526-DE21427317C7Q37638402-34CD8325-307D-4A3E-B834-A01093C5286DQ38136067-5A5459C4-59BA-40FB-874D-919C12B46C1FQ38160083-89026B7F-D2B9-4AA0-A950-7C90A813DDF4Q38204774-7150253C-2EE2-4055-8931-084CDC19F858Q38534169-54609A4D-6EEC-4D3C-BE4B-95610E37797EQ38660898-2BFCA35C-D8DE-4219-B416-A847F504E4E3Q39322780-8322DA79-CE3D-4D89-8359-260198E6AA60Q39683233-A7B4286F-5A6B-4317-9AA8-E43AF3A05566Q40052934-83F84888-49B4-4257-9B11-E144157736F1Q40058830-EE242190-BFF9-463E-B504-AD60726B1E1AQ40073913-BE2885A9-495B-4280-9C54-30D1D83A1E25Q40082914-0998A5CA-65A7-414C-854B-E1E45CF40040Q41172374-7A841883-E421-412F-AB99-2995B2D6388DQ41389931-330774B1-0DDF-4985-8AB9-3D08F636FE72Q50420352-A85E5A74-04E0-460B-8942-3E5037A6148FQ52579975-8DC0034E-1BC4-4FD3-9418-4C040E57055FQ55038946-540CA731-C9DE-44CC-A5A9-30A04B407D73Q55244066-D0A955CD-716C-47E9-AB88-30253F41B6F8
P2860
A randomized trial of candidate inactivated quadrivalent influenza vaccine versus trivalent influenza vaccines in children aged 3-17 years.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
A randomized trial of candidat ...... s in children aged 3-17 years.
@en
type
label
A randomized trial of candidat ...... s in children aged 3-17 years.
@en
prefLabel
A randomized trial of candidat ...... s in children aged 3-17 years.
@en
P2093
P2860
P356
P1476
A randomized trial of candidat ...... s in children aged 3-17 years.
@en
P2093
Bruce L Innis
Carine Claeys
Heidemarie Pankow-Culot
Joseph B Domachowske
Mathieu Peeters
Milagros Bautista
Varsha Jain
P2860
P304
P356
10.1093/INFDIS/JIT091
P407
P577
2013-03-07T00:00:00Z